DUBLIN–(BUSINESS WIRE)–The “Organ Preservation Market Analysis by Solution, by Technique, by Organ Type, End user and by Region – Global Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering.
The organ preservation market size is estimated to be USD 462 million in 2021 and is expected to witness a CAGR of 8.17% during the forecast period 2022-2029. The rising focus on patient engagement and advantages of CRM software are some of the key drivers for the market growth. Furthermore, presence of key players is expected to contribute the market growth. However, increasing cost of implementation and security issues of data are expected to restrain the market growth.
By Solution
Based on solution, the market is segregated into custodial HTK, University Of Wisconsin solution, perfadex, and others. In 2021, the University Of Wisconsin solution segment accounted for the highest revenue share due to enhanced physiological function of the organs in comparison to other treatments and the growing use of UW solution because it contains substrates that are metabolically inactive, such as raffinose and lactobionate, which improve transplantation results and reduce histological damage.
By Technique
On the basis of technique, the market is categorized into normothermic machine perfusion, hypothermic machine perfusion, and static cold storage. In 2021, the static cold segment accounted for the highest revenue share owing to its broad application and rising usage.
By Organ Type
Based on organ type, the market is divided into pancreas, kidney, lungs, liver, and heart. In 2021, the kidney segment accounted for the highest revenue share due to rising the number of kidney transplant operations and occurrences of renal failure.
By End user
On the basis of end user, the market is segregated into specialty clinics, organ transplant centres, and hospitals. In 2021, the organ transplant centers segment accounted for the highest revenue share owing to the growing number of transplant facilities worldwide.
Regional Markets
In 2021, North America region accounted for the highest revenue in the organ preservation market and is expected to maintain its dominance during the forecast period. This is attributed to growing demand for and acceptance of organ transplantation as a result of increasing number of chronic diseases, and region’s requirement for preservation solutions to safeguard organ viability in ex-vivo situations.
Segmentation: Organ Preservation Market Report 2021-2029
By Solution (Revenue, USD Million)
Custodial HTK
University of Wisconsin Solution
Perfadex
Others
By Technique (Revenue, USD Million)
Normothermic Machine Perfusion
Hypothermic Machine Perfusion
Static Cold Storage
Organ Type (Revenue, USD Million)
Pancreas
Kidney
Lungs
Liver
Heart
By End user (Revenue, USD Million)
Specialty Clinics
Organ Transplant Centres
Hospitals
By Region (Revenue, USD Million)
North America
U.S
Canada
Europe
Germany
France
UK
Spain
Italy
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Rest of LATAM
Middle East & Africa
South Africa
GCC
Rest of MEA
Key Topics Covered:
1. Research Methodology
2. Introduction: Organ Preservation
3. Executive Summary
4. Market Dynamics
5. Market Environment Analysis
6. COVID-19 Impact Analysis: Organ Preservation Market
7. Market Analysis by Solutions
8. Market Analysis by Technique
9. Market Analysis by Organ Type
10. Market Analysis by End user
11. Regional Market Analysis
12. North America Organ Preservation Market
11. Europe Organ Preservation Market
12. Asia Pacific Organ Preservation Market
13. Latin America Organ Preservation Market
14. MEA Organ Preservation Market
15. Competitor Analysis
16. Company Profiles
17. Conclusion & Recommendations
Companies Mentioned
Paragonix Technologies (US)
XVIVO Perfusion AB (Sweden)
Dr. Franz Kohler Chemie GmbH (Germany)
Essential Pharmaceuticals LLC (US)
TransMedics (US)
OrganOx Limited (UK)
21st Century Medicine (US)
Shanghai Genext Medical Technology (China)
Bridge to Life Limited (US)
Waters Medical Systems (US)
Preservation Solutions (US)
Carnamedica (Poland)
Transplant Biomedicals (Spain)
Institut Georges Lopez (France)
Global Transplant Solutions (US)
Avionord (Italy)
Organ Preservation Solutions (England)
EBERS (Spain)
S.A.L.F. (Italy)
Biochefa (Poland)
Vascular Perfusion Solutions (US)
TX Innovations (Netherlands).
For more information about this report visit https://www.researchandmarkets.com/r/d4dg3z
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
